{
    "nct_id": "NCT02843945",
    "official_title": "Initial Feasibility Study to Evaluate the Safety and Efficacy of the Permanently Implantable LDR CivaSheet® in Combination With External Beam Radiation in the Treatment of Pancreatic Cancer",
    "inclusion_criteria": "* • Subject signed inform consent\n\n  * Age > 18 years\n  * Not pregnant or breast feeding\n  * Patient capable of undergoing anesthesia\n  * Patient selected to undergo Whipple procedure or distal pancreatectomy\n  * Patient does not have metastatic disease\n  * Patients will have close margins\n  * No prior radiation therapy to the region for separate cancer\n  * Confirmed diagnosis of borderline resectable or locally advanced pancreatic adenocarcinoma\n  * Patient Received neoadjuvant chemoradiation (4-10 weeks prior to surgery)\n  * Chemotherapy was administered for 2-6 cycles with any combination of the following agents:\n  * Gemcitabine + nb-paclitaxel\n  * FOLFIRINOX\n  * Neoadjuvant Chemoradiation was administered as IMRT or 3DCRT (up to 56 Gy), or SBRT (up to 36 Gy) with Pre-operative External beam dose (NCCN)\n  * up to 56 Gy (1.8-2.0 Gy per fractions) with concurrent gemcitabine, capecitabine, or infusional 5-fluorouracil\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Not surgical candidate\n* Any other invasive cancer in the past 5 years, except basal cell or squamous cell skin cancer\n* An IRE candidate (IRE is Percutaneous irreversible electroporation)\n* Recurrent or previously resected tumors\n* Documented History of Alcoholism and or drug abuse\n* Participant in other clinical trials",
    "miscellaneous_criteria": ""
}